Search

With notable cases of pancreatic cancer in the news this year, MSK held an Information Session for Patients and Caregivers with the goal of helping people understand the disease and sharing some of the encouraging breakthroughs in research and treatment.

… Monday, November 23, 2020 With notable cases of pancreatic cancer in the news this year, MSK held an Information Session for Patients and Caregivers with the goal of helping people understand the disease and sharing some of the encouraging breakthroughs in research and treatment. The session was moderated

Memorial Sloan Kettering Cancer Center (MSK) has welcomed Whitney Snider, MD, MBA, as the inaugural Managing Partner of MSK Ventures – a dedicated investment pool that will raise and direct funds to high-growth, early-stage startups created and/or nurtured by MSK faculty and staff.

… Tuesday, January 20, 2026 Memorial Sloan Kettering Cancer Center (MSK) has welcomed Whitney Snider, MD, MBA, as the inaugural Managing Partner of MSK Ventures – a dedicated investment pool that will raise and direct funds to high-growth, early-stage startups created and/or nurtured by MSK faculty and

… Monday, September 26, 2022 Memorial Sloan Kettering Cancer Center (MSK) is marking a year since the launch of MSK Telemedicine – an online solution for remote care that has been used for more than 200,000 appointments since its launch last August. MSK Telemedicine, created to provide patients access

Learn about new findings regarding how inherited and acquired genetic mutations cause breast cancer resistance to certain therapies.

… Wednesday, March 4, 2026 Researchers at Memorial Sloan Kettering Cancer Center (MSK) have made an important discovery about how genetic mutations in  breast cancer patients can interact and drive resistance to certain drugs called CDK4/6 inhibitors. This finding, published in  Nature , suggests a new

Two pivotal studies published in the New England Journal of Medicine and conducted by Memorial Sloan Kettering researchers offer proof of better treatment options for patients with advanced renal cell carcinoma (RCC), the most common form of kidney cancer.

… Saturday, September 26, 2015 Two pivotal studies published in the New England Journal of Medicine and conducted by Memorial Sloan Kettering researchers offer proof of better treatment options for patients with advanced renal cell carcinoma (RCC), the most common form of kidney cancer. In the studies,

Catch up with some of the patients we got to know in 2017.

… Thursday, December 28, 2017 Everyone touched by cancer has a story to tell. We reconnected with just a few of the inspiring people we met in 2017 to see how they’re doing today. Tim Waples It’s been five years since Tim, a special education teacher from Emerson, New Jersey, completed treatment for non-Hodgkin

At Memorial Sloan Kettering Cancer Center, more than half of patients with gallbladder cancer are diagnosed incidentally following elective cholecystectomy for assumed benign disease. The traditional treatment approach for these patients is re-resection to achieve a cure.

… Monday, November 11, 2019 At Memorial Sloan Kettering Cancer Center, more than half of patients with gallbladder cancer are diagnosed incidentally following elective cholecystectomy for assumed benign disease. The traditional treatment approach for these patients is re-resection to achieve a cure. Gallbladder

The multicenter project, which yielded dozens of scientific papers on more than 30 different kinds of cancer, has officially drawn to a close.

… Friday, January 4, 2019 Summary This wide-ranging effort, which was jointly funded by the National Human Genome Research Institute and the National Cancer Institute, has been completed. When The Cancer Genome Atlas (TCGA) launched in 2005, the understanding of the genetic changes that drive cancer was

Experts from Memorial Sloan Kettering presented some of the latest research on this challenging complication of many cancer surgeries.

… Friday, December 7, 2018 Summary Cancer-related lymphedema is one of the most challenging long-term side effects that can occur after cancer surgery. It can greatly impact a person’s quality of life. Cancer-related lymphedema is one of the most challenging long-term side effects that can occur after

A leader in developing better treatments for a range of blood cancers, Dr. Omar Abdel-Wahab is only the second person from MSK to receive the Paul Marks Prize for Cancer Research. 

… Monday, December 1, 2025 For more than two decades, physician-scientist Omar Abdel-Wahab, MD , has been known around Memorial Sloan Kettering Cancer Center (MSK) for his insight, knowledge, and creativity as a cancer researcher.   Now he will also be known as a Paul Marks Prize winner , the first recipient